anti-PD(L)1

PD-1/PD-L1 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anti-PD(L)1, covering 2021-12-15 to 2021-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma [Phase 2]